Dynamine and Caffeine Together: What the Research Actually Found

Dynamine and Caffeine Together: What the Research Actually Found

Methylliberine (sold as Dynamine) roughly doubles caffeine's half-life when the two are taken together. In a randomized, double-blind crossover study of 12 adults, co-administration with 100 mg methylliberine extended caffeine's half-life from 7.15 hours to 14.7 hours and cut its oral clearance by nearly 60%, while peak caffeine concentration stayed the same (Mondal et al. 2022). Same peak, longer tail. That is a duration effect, not an intensity effect, and the researchers flagged it as an enzyme-inhibition signal, not a proven benefit.

Here is what you need to know before combining the two.

Key Takeaways

• Methylliberine inhibits CYP1A2, the liver enzyme responsible for clearing caffeine, which extends caffeine's time in your system without raising its peak blood level.
• Two separate human trials found that a caffeine-methylliberine-theacrine stack matched or beat caffeine alone on reaction time and alertness, with fewer reported side effects, though neither study can isolate methylliberine's contribution.
• A doubled caffeine half-life has a real downside: afternoon doses linger well into the night. Timing matters more than dose.
• The longest safety trial ran 4 weeks. Anything beyond that is uncharted.

What happens when you take Dynamine and caffeine together?

Methylliberine slows caffeine's breakdown by inhibiting CYP1A2, the cytochrome P450 enzyme that handles roughly 95% of caffeine metabolism. The result is more total caffeine exposure over a longer window, with no spike in peak concentration. The study that measured this (Mondal et al. 2022, n=12, 6 male, 6 female, randomized double-blind crossover with 24-hour blood sampling via UPLC-MS/MS) used 100 mg methylliberine co-administered with 150 mg caffeine. Those are the study doses, not a dosing recommendation.

Here are the before-and-after numbers, taken directly from the study's tables:

A citation-hygiene note: this paper's abstract and discussion contain statements that contradict its own data tables. The numbers above come from the tables, which is where the raw pharmacokinetic data lives. If you check the abstract, you will find discrepancies. Trust the tables.

Why does this matter practically?

The unchanged Cmax is the most underappreciated line in that table. Competitor pages routinely claim that Dynamine "amplifies" or "boosts" caffeine. It does not. Your peak caffeine level stays the same. What changes is how long caffeine sticks around. That distinction matters because a higher peak would mean more jitters and a harder crash. Instead, the pharmacokinetic profile shows the same onset, the same ceiling, and a much longer decline.

The mechanism, CYP1A2 inhibition, is well-characterized in pharmacology. Grapefruit juice, fluvoxamine, and oral contraceptives all slow caffeine clearance through overlapping pathways. The authors of the Mondal study explicitly frame this as a drug-interaction signal, noting that people taking other CYP1A2-dependent medications should be cautious. This is not a fringe warning; it is the central finding of the paper.

What does this mean for timing and sleep?

If methylliberine roughly doubles caffeine's half-life, an afternoon cup of coffee no longer clears the way you expect. A dose taken at 2 PM with a 7-hour half-life would be about 50% cleared by 9 PM. Double that half-life to 14 hours, and only about 29% is cleared by 9 PM. That is a meaningful difference for sleep.

Methylliberine itself is not the sleep concern. Its own half-life is short, roughly 1.0 to 1.5 hours (Mondal et al. 2022). It enters and exits your system fast. But while it is active, it changes how long the caffeine beside it stays elevated. The practical consequence: if you combine the two, treat your caffeine as though you took it later in the day than you actually did.

Users in nootropics communities have independently described this sequencing. Methylliberine hits fast and fades fast. Theacrine is slower and much longer. Caffeine sits in the middle, and when paired with methylliberine, its tail extends. These reports are consistent with the measured pharmacokinetics, though community experience is not clinical evidence.

No study has measured whether the extended caffeine exposure feels better. That is an open question, and anyone who tells you it definitively improves focus or mood is running ahead of the data.

What the human trials found

Two controlled trials have tested caffeine-methylliberine combinations in humans. Both are worth knowing, and both have the same limitation: they used three-ingredient stacks (caffeine + methylliberine + theacrine), so you cannot attribute the results to methylliberine alone.

Cintineo et al. 2022: tactical personnel (n=48)

This randomized, double-blind, placebo-controlled trial enrolled 48 tactical personnel and compared three arms: placebo, 300 mg caffeine alone, and a combination of 150 mg caffeine + 100 mg methylliberine + 50 mg theacrine (CMT). No conflict of interest was reported.

The headline result: the CMT stack matched 300 mg of caffeine on vigilance reaction-time improvement while using half the caffeine dose. Both active arms raised systolic blood pressure, but only the caffeine-alone arm raised diastolic blood pressure. That hemodynamic difference is the strongest single data point favoring the combination over caffeine alone.

This is the cleanest trial in the literature for one specific claim: you may be able to get equivalent alertness from less caffeine if you add methylliberine and theacrine. But "may" is doing work here. It is one study, n=48, and the CMT arm also contained theacrine.

Tartar et al. 2021: male esports players (n=50)

A repeated-measure randomized crossover trial gave 50 male esports players one of three treatments across three sessions spaced a week apart: 125 mg caffeine alone, a CDT combination (125 mg caffeine + 75 mg methylliberine + 50 mg theacrine), or placebo.

The CDT group improved on Flanker inhibitory control and Psychomotor Vigilance Task reaction time. The mood data told an interesting story: caffeine alone increased self-reported anxiety compared to placebo, while the combination increased alertness without the anxiety bump. Caffeine alone also produced more headaches than the combination.

That pattern, same or better cognitive performance with fewer subjective side effects, appeared in both trials. It is suggestive but not conclusive. Three ingredients were present in both stacks, and isolating methylliberine's specific contribution is not possible from this design.

A note on funding

Most of the positive human research on methylliberine and theacrine has been funded by Compound Solutions, the company that manufactures the branded ingredients (Dynamine and TeaCrine). The Cintineo 2022 trial was also funded by Compound Solutions, though its authors separately reported no conflict of interest. The Tartar 2021 trial was published in Cureus. Independently funded studies on these compounds tend to show more modest or null results. That does not invalidate the industry-funded work, but you should weigh it accordingly.

Is Dynamine and caffeine together safe?

The longest controlled safety trial is VanDusseldorp et al. 2020, which followed 125 participants over 4 weeks across arms that included methylliberine alone and methylliberine plus theacrine. No clinically significant changes in cardiovascular markers or blood biomarkers were observed; everything stayed within normal reference ranges. This study was funded by Compound Solutions.

Four weeks is the ceiling of the human safety data. If you are combining methylliberine and caffeine for longer than a month, you are past the tested window, and no one can tell you the long-term risk profile with confidence.

The CYP1A2 interaction deserves its own safety mention. If you take any medication metabolized by CYP1A2 (common examples include certain antidepressants, antipsychotics, and cardiovascular drugs), adding methylliberine could change how those drugs are cleared. Talk to your prescriber before combining. This is not a theoretical concern; it is the direct pharmacological implication of the mechanism the Mondal study measured.

Other practical safety points:

• The Cintineo trial (n=48) found that the combination arm did not raise diastolic blood pressure, while 300 mg caffeine alone did. That is reassuring but limited to a single acute dose.
• The standard deviations on caffeine half-life in the Mondal study (±5.59 h alone, ±5.8 h together) are wide. Individual variation is large. Your response could be much shorter or much longer than the mean.
• No study has tested methylliberine in pregnant or breastfeeding people, or in anyone under 18.

Where the Evidence Stands Today

Methylliberine extends caffeine's duration without raising its peak, likely through CYP1A2 inhibition. Two human performance trials suggest the combination (with theacrine) may deliver equivalent alertness to higher caffeine doses with a milder side-effect profile. The safety data covers 4 weeks in 125 people. Everything beyond that is extrapolation.

The strongest case for combining the two is the pharmacokinetic math: if you want longer-lasting caffeine without simply drinking more of it, slowing its clearance is a logical route. The strongest case for caution is the same math in reverse: a caffeine dose that used to clear by bedtime may not anymore, and anyone on CYP1A2-dependent medication should treat this as a real interaction.

Frequently Asked Questions

Does Dynamine make caffeine stronger?

Not in the way most people mean. Methylliberine does not increase caffeine's peak blood concentration (Cmax), so the initial "hit" is unchanged. What it does is slow caffeine's clearance by inhibiting the CYP1A2 enzyme, roughly doubling the half-life in the one human PK study (n=12) that measured it. The effect is longer duration, not greater intensity.

Can you take Dynamine with caffeine every day?

The longest safety study (VanDusseldorp et al. 2020) ran for 4 weeks with 125 participants and found no clinically significant changes. Beyond that window, there is no controlled human data. If you take CYP1A2-dependent medications, consult your doctor first, because methylliberine may alter how those drugs are cleared.

What is the right ratio of Dynamine to caffeine?

No study has tested multiple ratios head-to-head, so there is no established "right" ratio. The pharmacokinetic study used 100 mg methylliberine with 150 mg caffeine. The performance trials used different amounts. Treat published study doses as study parameters, not prescriptions.

Does the Dynamine-caffeine combination cause jitters?

In the Tartar 2021 trial (n=50), caffeine alone increased self-reported anxiety while the caffeine-methylliberine-theacrine combination increased alertness without an anxiety increase. The Cintineo 2022 trial (n=48) found that only caffeine alone raised diastolic blood pressure. Both results are suggestive but involved three-ingredient stacks, so methylliberine alone cannot get the credit.

How long does the effect of Dynamine and caffeine last?

Methylliberine itself has a short half-life of about 1.0 to 1.5 hours. But its effect on caffeine's clearance means the caffeine stays elevated longer. The PK study measured a caffeine half-life of about 14.7 hours when co-administered, versus about 7.15 hours alone. Felt effects depend on the individual and the caffeine dose.

Is Dynamine the same as theacrine?

No. Both are methyluric acid derivatives (methylurates), not methylxanthines like caffeine. But they behave differently. Methylliberine is fast-acting with a short half-life. Theacrine has a much longer half-life (measured at 16.5 to 29.2 hours, dose-dependent). Their mechanisms for interacting with caffeine also differ: methylliberine slows caffeine's clearance, while caffeine improves theacrine's bioavailability. Read more in our methylliberine guide.

Should I take Dynamine and caffeine in the morning or afternoon?

Given the extended caffeine half-life, earlier is safer for sleep. If methylliberine roughly doubles caffeine's clearance time, an afternoon combination could leave meaningful caffeine levels in your system at midnight. No study has tested optimal timing, but the pharmacokinetics strongly favor morning or early-afternoon use, with at least 8 hours before bed.

Is methylliberine (Dynamine) natural or synthetic?

The commercially available ingredient (Dynamine) is synthetic. Methylliberine occurs naturally in Coffea species, not in kucha tea (that is theacrine, which competitors frequently confuse with methylliberine). The synthetic version is chemically identical to the natural compound.

A Caffeine Extender, Not a Caffeine Replacement

If the pharmacokinetics above match the problem you are trying to solve, longer-lasting focus from a moderate caffeine dose, Roon was built around exactly this mechanism. Each pouch combines caffeine, L-theanine, methylliberine (Dynamine), and theacrine (TeaCrine) in a sublingual format designed for a 5 to 10 minute onset and a 6 to 8 hour working window.

A point of honesty: the Mondal PK study used 100 mg methylliberine and 150 mg caffeine. The direction of the effect, slower caffeine clearance through CYP1A2 inhibition, is what the study established, but the magnitude at other doses has not been measured. The 6 to 8 hour window is what users consistently report, not a direct extrapolation from the study's numbers.

Roon is not a substitute for sleep, and it is not a tool for people who need to address caffeine sensitivity. It contains caffeine and will build tolerance like any caffeine source. Because the methylliberine-caffeine interaction extends caffeine clearance, it is sensible to stop well before bed. For anyone on CYP1A2-dependent medications, check with your prescriber before adding any methylliberine-containing product. If the timing works for your day, try Roon.

Written by Roon Team